Advertisement

Observations on Receptor Sites for Dihydropyridines

  • Peter Bellemann
Part of the Methodological Surveys in Biochemistry and Analysis book series (MSBA, volume 13)

Abstract

Amongst calcium-entry blockers (‘calcium antagonists’), important in cardiovascular therapy [1–3], some have a dihydropyridine (DHP) structure — notably nifedipine [4] and its newly synthesized analogue nimodipine [5, 6].

Keywords

Specific Binding Receptor Site Displacement Experiment Cation Modulation Cortical Membrane 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fleckenstein, A. (1977) Ann. Rev. Pharmacol. Toxicol. 17, 149–166.CrossRefGoogle Scholar
  2. 2.
    Rosenberg, L. & Triggle, D.J. (1978) in Calcium in Drug Action (Weiss, G.B., ed.), Plenum, New York, pp. 3–31.CrossRefGoogle Scholar
  3. 3.
    Meyer, H., Bossert, F., Wehinger, E., Towart, R. & Bellemann, P. (1983) Hypertension, in press.Google Scholar
  4. 4.
    Vater, W., Kroneberg, G., Hoffmeister, F., Kaller, H., Meng, K., Oberdorf, A., Puls, W., Schlossmann, K. & Stoepel, K. (1972) Arzneim.-Forsch. [Drug Res.] 22, 1–14.Google Scholar
  5. 5.
    Hoffmeister, F., Benz, U., Heise, A., Krause, H.P. & Neuser, V. (1982) Arzneim.-Forsch. 32, 347–360.Google Scholar
  6. 6.
    Towart, R., Wehinger, E., Meyer, H. & Kazda, S. (1982) Arzneim.-Forsch. 32, 338–346.Google Scholar
  7. 7.
    Bellemann, P., Ferry, D., Lübbecke, F. & Glossmann, H. (1981) Arzneim.-Forsch. 31, 2064–2067.Google Scholar
  8. 8.
    Bolger, G.T., Gengo, P.J., Luchowski, E.M., Siegel, H., Triggle, D.J. & Janis, R.A. (1982) Biochem. Biophys. Res. Comm. 104, l604-l609.CrossRefGoogle Scholar
  9. 9.
    Ehlert, F.J., Itoga, E., Roeske, W.R. & Yamamura, H.I. (1982) Biochem. Biophys. Res. Comm. 104, 937–943.CrossRefGoogle Scholar
  10. 10.
    Bradford, M.M. (1976) Anal. Biochem. 72, 248–253.CrossRefGoogle Scholar
  11. 11.
    Towart, R., Wehinger, E. & Meyer, H. (1981) Naunyn-Schmiede-berg’s Arch. Pharmacol. 317, 183–185.CrossRefGoogle Scholar
  12. 12.
    Bellemann, P., Schade, A. & Towart, R. (1983) Proc. Nat. Acad. Sci. 80, 2356–2360. [This paper, unlike the present article, is not confined to cortex; cf. allusion to “regions’’ early in the present text.- Ed.] CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Peter Bellemann
    • 1
  1. 1.Department of PharmacologyBayer AGWuppertalW. Germany

Personalised recommendations